|
AstraZeneca and PatientsLikeMe announce global research collaboration
|
13 April 2015 |
|
AstraZeneca joins Genomics England consortium
|
27 March 2015 |
|
AstraZeneca to collaborate with the Harvard Stem Cell Institute in diabetes
|
25 March 2015 |
|
AstraZeneca announces positive Phase III top-line results for PT003 from PINNACLE 1 and PINNACLE 2 studies in COPD
|
18 March 2015 |
|
PEGASUS-TIMI 54 study shows that long-term treatment with BRILINTA reduced thrombotic cardiovascular events in patients with a history of heart attack
|
16 March 2015 |
|
AstraZeneca completes acquisition of rights to Actavis’ branded respiratory portfolio in the US and Canada
|
03 March 2015 |
|
AstraZeneca to acquire rights to Actavis’ branded respiratory portfolio in the US and Canada
|
05 February 2015 |
|
AstraZeneca announces collaborations to use CRISPR technology for genome editing across its drug discovery platform
|
29 January 2015 |
|
MedImmune enters licensing agreement with Omnis Pharmaceuticals for oncolytic viruses in immuno-oncology
|
12 January 2015 |
|
Jury verdict favours AstraZeneca in Nexium antitrust litigation
|
05 December 2014 |